2025-04-012026-03-312026-03-31false10090302OPTOVUE LTD2026-09-0986900falseiso4217:GBPxbrli:pure100903022025-03-31100903022026-03-31100903022025-04-012026-03-31100903022024-03-31100903022025-03-31100903022024-04-012025-03-3110090302bus:SmallEntities2025-04-012026-03-3110090302bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3110090302bus:FullAccounts2025-04-012026-03-3110090302bus:PrivateLimitedCompanyLtd2025-04-012026-03-3110090302core:WithinOneYear2026-03-3110090302core:AfterOneYear2026-03-3110090302core:WithinOneYear2025-03-3110090302core:AfterOneYear2025-03-3110090302core:ShareCapital2026-03-3110090302core:SharePremium2026-03-3110090302core:RevaluationReserve2026-03-3110090302core:OtherReservesSubtotal2026-03-3110090302core:RetainedEarningsAccumulatedLosses2026-03-3110090302core:ShareCapital2025-03-3110090302core:SharePremium2025-03-3110090302core:RevaluationReserve2025-03-3110090302core:OtherReservesSubtotal2025-03-3110090302core:RetainedEarningsAccumulatedLosses2025-03-3110090302core:LandBuildings2026-03-3110090302core:PlantMachinery2026-03-3110090302core:Vehicles2026-03-3110090302core:FurnitureFittings2026-03-3110090302core:OfficeEquipment2026-03-3110090302core:NetGoodwill2026-03-3110090302core:IntangibleAssetsOtherThanGoodwill2026-03-3110090302core:ListedExchangeTraded2026-03-3110090302core:UnlistedNon-exchangeTraded2026-03-3110090302core:LandBuildings2025-03-3110090302core:PlantMachinery2025-03-3110090302core:Vehicles2025-03-3110090302core:FurnitureFittings2025-03-3110090302core:OfficeEquipment2025-03-3110090302core:NetGoodwill2025-03-3110090302core:IntangibleAssetsOtherThanGoodwill2025-03-3110090302core:ListedExchangeTraded2025-03-3110090302core:UnlistedNon-exchangeTraded2025-03-3110090302core:LandBuildings2025-04-012026-03-3110090302core:PlantMachinery2025-04-012026-03-3110090302core:Vehicles2025-04-012026-03-3110090302core:FurnitureFittings2025-04-012026-03-3110090302core:OfficeEquipment2025-04-012026-03-3110090302core:NetGoodwill2025-04-012026-03-3110090302core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110090302core:ListedExchangeTraded2025-04-012026-03-3110090302core:UnlistedNon-exchangeTraded2025-04-012026-03-3110090302core:MoreThanFiveYears2025-04-012026-03-3110090302core:Non-currentFinancialInstruments2026-03-3110090302core:Non-currentFinancialInstruments2025-03-3110090302dpl:CostSales2025-04-012026-03-3110090302dpl:DistributionCosts2025-04-012026-03-3110090302core:LandBuildings2025-04-012026-03-3110090302core:PlantMachinery2025-04-012026-03-3110090302core:Vehicles2025-04-012026-03-3110090302core:FurnitureFittings2025-04-012026-03-3110090302core:OfficeEquipment2025-04-012026-03-3110090302dpl:AdministrativeExpenses2025-04-012026-03-3110090302core:NetGoodwill2025-04-012026-03-3110090302core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3110090302dpl:GroupUndertakings2025-04-012026-03-3110090302dpl:ParticipatingInterests2025-04-012026-03-3110090302dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3110090302core:ListedExchangeTraded2025-04-012026-03-3110090302dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3110090302core:UnlistedNon-exchangeTraded2025-04-012026-03-3110090302dpl:CostSales2024-04-012025-03-3110090302dpl:DistributionCosts2024-04-012025-03-3110090302core:LandBuildings2024-04-012025-03-3110090302core:PlantMachinery2024-04-012025-03-3110090302core:Vehicles2024-04-012025-03-3110090302core:FurnitureFittings2024-04-012025-03-3110090302core:OfficeEquipment2024-04-012025-03-3110090302dpl:AdministrativeExpenses2024-04-012025-03-3110090302core:NetGoodwill2024-04-012025-03-3110090302core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110090302dpl:GroupUndertakings2024-04-012025-03-3110090302dpl:ParticipatingInterests2024-04-012025-03-3110090302dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110090302core:ListedExchangeTraded2024-04-012025-03-3110090302dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110090302core:UnlistedNon-exchangeTraded2024-04-012025-03-3110090302core:NetGoodwill2026-03-3110090302core:IntangibleAssetsOtherThanGoodwill2026-03-3110090302core:LandBuildings2026-03-3110090302core:PlantMachinery2026-03-3110090302core:Vehicles2026-03-3110090302core:FurnitureFittings2026-03-3110090302core:OfficeEquipment2026-03-3110090302core:AfterOneYear2026-03-3110090302core:WithinOneYear2026-03-3110090302core:ListedExchangeTraded2026-03-3110090302core:UnlistedNon-exchangeTraded2026-03-3110090302core:ShareCapital2026-03-3110090302core:SharePremium2026-03-3110090302core:RevaluationReserve2026-03-3110090302core:OtherReservesSubtotal2026-03-3110090302core:RetainedEarningsAccumulatedLosses2026-03-3110090302core:NetGoodwill2025-03-3110090302core:IntangibleAssetsOtherThanGoodwill2025-03-3110090302core:LandBuildings2025-03-3110090302core:PlantMachinery2025-03-3110090302core:Vehicles2025-03-3110090302core:FurnitureFittings2025-03-3110090302core:OfficeEquipment2025-03-3110090302core:AfterOneYear2025-03-3110090302core:WithinOneYear2025-03-3110090302core:ListedExchangeTraded2025-03-3110090302core:UnlistedNon-exchangeTraded2025-03-3110090302core:ShareCapital2025-03-3110090302core:SharePremium2025-03-3110090302core:RevaluationReserve2025-03-3110090302core:OtherReservesSubtotal2025-03-3110090302core:RetainedEarningsAccumulatedLosses2025-03-3110090302core:NetGoodwill2024-03-3110090302core:IntangibleAssetsOtherThanGoodwill2024-03-3110090302core:LandBuildings2024-03-3110090302core:PlantMachinery2024-03-3110090302core:Vehicles2024-03-3110090302core:FurnitureFittings2024-03-3110090302core:OfficeEquipment2024-03-3110090302core:AfterOneYear2024-03-3110090302core:WithinOneYear2024-03-3110090302core:ListedExchangeTraded2024-03-3110090302core:UnlistedNon-exchangeTraded2024-03-3110090302core:ShareCapital2024-03-3110090302core:SharePremium2024-03-3110090302core:RevaluationReserve2024-03-3110090302core:OtherReservesSubtotal2024-03-3110090302core:RetainedEarningsAccumulatedLosses2024-03-3110090302core:AfterOneYear2025-04-012026-03-3110090302core:WithinOneYear2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3110090302core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3110090302core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3110090302core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110090302core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110090302core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110090302bus:Director12025-04-012026-03-3110090302bus:Director22025-04-012026-03-31

OPTOVUE LTD

Registered Number
10090302
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

OPTOVUE LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

Dr Afsar Jalil Jafree
Shazia Afsar Jafree

Registered Address

Victoria Court
17-21 Ashford Road
Maidstone
ME14 5DA

Registered Number

10090302 (England and Wales)
OPTOVUE LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets346,99459,157
46,99459,157
Current assets
Debtors4390,743396,535
Cash at bank and on hand154,935107,052
545,678503,587
Creditors amounts falling due within one year5(16,389)(18,234)
Net current assets (liabilities)529,289485,353
Total assets less current liabilities576,283544,510
Provisions for liabilities6(8,929)(11,240)
Net assets567,354533,270
Capital and reserves
Called up share capital100100
Profit and loss account567,254533,170
Shareholders' funds567,354533,270
The financial statements were approved and authorised for issue by the Board of Directors on 9 September 2026, and are signed on its behalf by:
Dr Afsar Jalil Jafree
Director
Registered Company No. 10090302
OPTOVUE LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered office address is Victoria Court, 17-21 Ashford Road, Maidstone, Kent, ME14 5DA.
Statement of compliance
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company's accounting policies.
Basis of preparation
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the company, and rounded to the nearest £1.
Revenue from sale of goods
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Deferred tax is not recognised in respect of permanent differences. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight line method. Depreciation is provided on the following basis:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Vehicles20-
Office Equipment-5
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.
2.Average number of employees

20262025
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Vehicles

Office Equipment

Total

££££
Cost or valuation
At 01 April 252,264111,94021,179135,383
At 31 March 262,264111,94021,179135,383
Depreciation and impairment
At 01 April 251,54854,62720,05176,226
Charge for year18011,46352012,163
At 31 March 261,72866,09020,57188,389
Net book value
At 31 March 2653645,85060846,994
At 31 March 2571657,3131,12859,157
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables-63,273
Amounts owed by associates and joint ventures / participating interests133,08685,773
Other debtors199,221192,824
Prepayments and accrued income58,43654,665
Total390,743396,535
5.Creditors: amounts due within one year

2026

2025

££
Taxation and social security12,86012,883
Accrued liabilities and deferred income3,5295,351
Total16,38918,234
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Provisions for liabilities
Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation. Provisions are charged as an expense to profit or loss in the year that the company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.

2026

2025

££
Net deferred tax liability (asset)8,92911,240
Total8,92911,240
7.Directors advances, credits and guarantees
Other debtors includes £148,950 directors loan account. Interest has been charged at 3.75%.